Early Diagnosis + Early Behavioral Intervention =
Better Outcomes for Children1
BioROSA’s Test Provides a New Way to Detect ASD
BioROSA is developing a highly accurate blood test that will detect ASD in children as young as 18 months.
Early Intervention Follows
A positive BioROSA test can allow for early intervention services to begin. Early intervention has been shown to improve language, social skills, and IQ for many children with ASD2.
Why it Matters
No Early Test Available
There is no broad-based molecular diagnostic test for clinicians to assess ASD risk on the market today5.
Determining ASD Risk Through Biology
The BioROSA test uses a small amount of blood taken from a standard blood draw. We measure a set of blood biomarkers that are predictors of ASD. Computer algorithms are applied to analyze data and provide a risk score for ASD.